University Of Calgary
Clinical trials sponsored by University Of Calgary, explained in plain language.
-
Heart pill hopes dashed: atrial fibrillation study shut down after just 3 patients
Disease control TerminatedThis study tested whether a single high dose (2000 mg) of the heart medication amiodarone, taken by mouth, could safely and quickly restore normal heart rhythm in people with acute atrial fibrillation. The trial planned to include both hospital and outpatient settings, but was te…
Phase: PHASE4 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Bone drug tested to save knees after ACL injury – but trial stalls
Disease control TerminatedThis early study tested whether a single infusion of zoledronic acid, a drug used for osteoporosis, could improve bone health and slow joint damage after an ACL tear. Only 4 people were enrolled before the trial was terminated, so the results are very limited. The study aimed to …
Phase: PHASE1 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New knee pain block fails to prove extra benefit in small trial
Symptom relief TerminatedThis study looked at whether adding an iPACK nerve block to standard pain treatments (adductor canal block and local injections) helps people feel less pain and recover faster after total knee replacement. Only 10 people were enrolled before the study was stopped early. The goal …
Phase: PHASE4 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC